openPR Logo
Press release

DDi Launches VISTAAR.ai to Accelerate Regulatory and Clinical Intelligence

04-05-2019 04:03 PM CET | IT, New Media & Software

Press release from: ddismart.com

/ PR Agency: DDI LLC
Global Regulatory and Clinical Intelligence platform

Global Regulatory and Clinical Intelligence platform

The growth in the number and complexity of regulations as well as quality standards will create challenges for companies to keep up. Traditional Regulatory intelligence (RI) systems are not keeping with changing times and adapting technology to get global Regulatory teams right Insights faster and cheaper. With a diversity of information sources, identifying and analyzing context based intelligence is challenging.

To address these, DDi brings VISTAAR.ai a Global Regulatory and Clinical Intelligence Platform which focuses exclusively on providing Regulatory Intelligence (RI) and Clinical Intelligence (Clin Intel) solution for drugs, devices, combination products, biologics, generics, active pharmaceutical ingredients and animal health drugs.

Vistaar combines regulatory content compiled by experts with advanced technology (AI) to deliver a unique intelligence solution addressing the regulatory landscape including Classification, Clinical, Marketing, Labeling, Safety, Variations, Imports/Exports and other key areas based on the inbuilt proprietary algorithms that align with regulatory and clinical business goals.

In 2013 VISTAAR knowledge base was developed and utilized internally by a consulting firm. DDi acquired this knowledge database last year and added newer technology to unlock this "knowledge" for users to use easily at an affordable cost.

Name: Susan Reeves,
Email: susan.reeves@vistaar.ai,
Address: Independence way, New Jersey, Princeton, US
Website: www.vistaar.ai

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release DDi Launches VISTAAR.ai to Accelerate Regulatory and Clinical Intelligence here

News-ID: 1690517 • Views:

More Releases from ddismart.com

TULA recognized by CIO Applications magazine as
TULA recognized by CIO Applications magazine as "Top 25 GRC Technology Providers …
In the wake of the growing need of GRC technology solutions across enterprises globally, CIO Applications has compiled a list of “Top 25 Governance, Risk, and Compliance Technology Providers 2017.” The compilation is a result of extensive research of GRC technology providers worldwide, conducted by the editorial team. DDi caters to Clinical, Regulatory, Safety, and Enterprise domains with its innovative technology products and automation solutions for Life Science organizations. DDi developed

More Releases for Regulatory

Medical Device Regulatory Affairs Market Medical Device Regulatory Affairs Marke …
"Medical Device Regulatory Affairs Market" in terms of revenue was estimated to be worth $ 6.7 billion in 2024 and is poised to reach $ 18.3 billion by 2034, growing at a CAGR of 10.8% from 2025 to 2034 according to a new report by InsightAce Analytic. Request For Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1913 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global medical device regulatory
Medical Device & IVD Regulatory Affairs Outsourcing Market: Navigating Regulator …
Global healthcare landscape, the Medical Device & IVD Regulatory Affairs Outsourcing Market has emerged as a critical component ensuring the safe and compliant introduction of medical devices and in-vitro diagnostic products to the market. As the industry witnesses significant shifts and challenges, here's an in-depth analysis of the current trends, dynamics, and future prospects within this market segment. Download sample PDF copy of report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=79264&utm_source=OpenPR_Ajay&utm_medium=OpenPR Impact of COVID-19 on European Regulations The outbreak of
Regulatory Writing Market - Clear, Concise, Compliant: Redefining Regulatory Wri …
Newark, New Castle, USA - new report, titled Regulatory Writing Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Regulatory Writing market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Regulatory Writing market. The report offers an overview of the market, which
Complex Regulatory Frameworks
It is challenging for new entrants to enter the FinTech industry because of its complex regulatory framework. All FinTech companies must comply with compliance requirements even before they begin operations, which increases their costs and creates a significant barrier for startups. While regulations are needed to protect consumers, a number of existing laws are slowing down the growth of many Indian FinTech companies, thereby extending their time to reach the
South Africa Upstream Fiscal and Regulatory Report 2017 - Pending Legislation Cr …
Presented report, South Africa Upstream Fiscal and Regulatory Report 2017 - Pending Legislation Creates Regulatory Uncertainty, presents the essential information relating to the terms which govern investment into South Africa’s upstream oil and gas sector. The report sets out in detail the contractual framework under which firms must operate in the industry, clearly defining factors affecting profitability and quantifying the state’s take from hydrocarbon production. Considering political, economic and industry
Regulatory Affairs Outsourcing Market (Services - Regulatory Submissions, Clinic …
This research study analyzes the market for regulatory affairs outsourcing services in terms of revenue (US$ Mn). The stakeholders of this report comprises the clinical research organizations. The global regulatory affairs outsourcing market has been broadly segmented on the basis of services (Regulatory Submissions, Clinical Trial Applications and Product Registrations, Regulatory Writing and Publishing, Regulatory Consulting and Legal Representation and others regulatory affairs, and Geography (North America, Europe, Asia Pacific,